drugset / Trial / NCT04922918

Ligilactobacillus Salivarius MP101 for Elderly in a Nursing Home

NCT04922918 ↗

Unknown 25 enrolled Universidad Complutense de Madrid
NaSingle-groupOpen-labelSupportive care

Summary

The objective of this work was to investigate the effect of Ligilactobacillus salivarius MP101 on the functional (Barthel index), cognitive (GDS/FAST) and nutritional (MNA) status, and on the nasal and fecal inflammatory profiles of elderly living in a nursing home highly affected by COVID-19.

Timeline

Start
2020-10-01
Primary completion
2021-06-24
Completion
2021-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ligilactobacillus salivarius MP101 Other / unclassified 9 unknown Oral

Indications